Mutations in a vital class of regulatory molecules are an underappreciated cause of cancer because they impair the function of "G" proteins, a versatile and vast family of signaling switches that underlie innumerable biological ...
If you've relied on taking herbal supplements to aid in weight loss, a recently published study has news for you.
Feb 26, 2020
0
3
People asked by experts to comment on the effectiveness of new psychiatric drug treatments appear to be unfairly biased even though they declare a conflict of interest, suggests research published online in the journal BMJ ...
Feb 4, 2020
0
1
The United States is working with a pharmaceutical company to develop a treatment for the 2019 Novel Coronavirus, using a class of drug that has boosted survival rates among Ebola patients, officials said Tuesday.
Feb 4, 2020
0
3
The World Health Organization warned Friday that a dire lack of new antibiotics was threatening efforts to curb the spread of drug-resistant bacteria, which kill tens of thousands of people each year.
Jan 17, 2020
0
2
(HealthDay)—The U.S. approval and regulation processes for pharmaceutical agents have evolved during the last four decades, according to a study published in the Jan. 14 issue of the Journal of the American Medical Association.
Jan 15, 2020
0
0
A new assessment of the Medicare Part D program based on a proposal from the West Health Policy Center finds that Medicare beneficiaries would save $29 billion if drug manufacturer rebates were used to reduce their out-of-pocket ...
Dec 19, 2019
0
1
Donald Trump's administration unveiled a plan Wednesday to allow imports of lower-priced prescription drugs from Canada and other countries, but it was opposed by Ottawa, which said the scheme threatened its own medicine ...
Dec 19, 2019
0
1
Donald Trump's administration unveiled a plan Wednesday to allow imports of lower-price prescription drugs from Canada and other countries, a top priority for the president ahead of next year's election.
Dec 18, 2019
0
4
A new drug candidate is more likely to be approved for use if it targets a gene known to be linked to the disease; a finding that can help pharmaceutical companies to focus their drug development efforts. Emily King and colleagues ...
Dec 12, 2019
0
14
